如果贵公司对该项目感兴趣，欢迎立即联系药时代BD团队！请发送邮件到BD@drugtimes.cn

In the early clinical development of atopic dermatitis (AD), multiple inflammatory factors…

If you are interested in this asset or need more information, please kindly contact DrugTimes BD Team at BD@drugtimes.cn, we will present the non-confidential deck to you for review asap. Many thanks!~

If you are interested in this asset or need more information, please kindly contact DrugTimes BD Team at BD@drugtimes.cn, we will present the non-confidential deck to you for review asap. Many thanks!~

If you are interested in this asset or need more information, please kindly contact DrugTimes BD Team at BD@drugtimes.cn, we will present the non-confidential deck to you for review asap. Many thanks!~

If you are interested in this asset or need more information, please kindly contact DrugTimes BD Team at BD@drugtimes.cn, we will present the non-confidential deck to you for review asap

If you are interested in this asset or need more information, please contact DrugTimes BD Team at BD@drugtimes.cn or visit our website at https://www.drugtimes.cn

If you are interested in this asset or need more information, please contact DrugTimes BD Team at BD@drugtimes.cn or visit our website at https://www.drugtimes.cn

If you are interested in this asset or need more information, please contact DrugTimes BD Team at BD@drugtimes.cn or visit our website at https://www.drugtimes.cn

If you are looking for brain-penetrating JAK1/TYK2 inhibitors, please contact DrugTimes BD Team at BD@drugtimes.cn asap

In the early clinical development of atopic dermatitis (AD), multiple inflammatory factors…

司美格鲁肽（GLP-1受体激动剂）可谓“出道即巅峰”——不仅成功俘获了马斯克的“芳心”，还被《Science》杂志评为2023年全球十大科学突破之首。同年，它还跃升为美国最畅销的处…

如果您有相关产品或信息，请速速联系药时代BD团队！

如果贵公司对这个出海机会感兴趣，请速速联系药时代BD团队！

如果贵公司对这个出海机会感兴趣，请速速联系药时代BD团队！

如果贵公司对这个机会感兴趣，请速速联系药时代BD团队！

If you are interested in this asset or need more information, please kindly contact DrugTimes BD Team at BD@drugtimes.cn, we will present the non-confidential deck to you for review asap. Many thanks!~

If you are interested in this asset or need more information, please kindly contact DrugTimes BD Team at BD@drugtimes.cn, we will present the non-confidential deck to you for review asap. Many thanks!~

If you are interested in this asset or need more information, please kindly contact DrugTimes BD Team at BD@drugtimes.cn, we will present the non-confidential deck to you for review asap. Many thanks!~

If you are interested in this asset or need more information, please kindly contact DrugTimes BD Team at BD@drugtimes.cn, we will present the non-confidential deck to you for review asap